EBS Новости Форекс
Emergent BioSolutions Appoints Joseph Papa As President And CEO
Specialty biopharmaceutical company Emergent BioSolutions Inc. (EBS) announced Wednesday that its Board of Directors has appointed Joseph Papa as president and CEO, effective February 21, 2024.
RTTNews
|
309 дней спустя
Emergent BioSolutions Says FDA Accepts AV7909 Anthrax Vaccine Candidate BLA For Review
Emergent BioSolutions Inc. (EBS) announced Friday that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted).
RTTNews
|
916 дней спустя
